Open AccessA PROSPECTIVE, NONRANDOMIZED TRIAL OF ALEMTUZUMAB FOR DESENSITIZATION OF WAITING LIST CANDIDATES WITH ANTI-HLA ANTIBODIES: AN INTERIM ANALYSIS.
Author(s) -
AUTHOR_ID
Publication year - 2006
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-200607152-02151
Subject(s) - alemtuzumab , interim , interim analysis , medicine , desensitization (medicine) , human leukocyte antigen , antibody , clinical trial , immunology , antigen , political science , law , receptor